Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rematin IBD
- Development stage
- Unknown
- Lead developer
- Waterley Pharmaceuticals
- Modality
- Small Molecules, Peptides
- Administration
- Oral
01
Overview
Rematin IBD is a specialized nutritional supplement developed by Waterley Pharmaceuticals for the supportive management of inflammatory bowel disease (IBD). It is a 100% soy-based, whole-protein powdered formulation designed to provide comprehensive nutritional support for patients with chronic intestinal inflammation. The product is naturally rich in flavonoids, which are intended to provide anti-inflammatory and immunomodulatory effects. It is formulated with a balanced profile of lipids and carbohydrates, along with a comprehensive suite of vitamins and minerals, including mecobalamin, folic acid, zinc, and magnesium. Rematin IBD is administered orally and is used to address the specific nutritional deficiencies and metabolic demands associated with IBD without a specific pharmacological mechanism of action.
- Brand names
- Rematin IBD
- Other names
- Rematin
Beyond the preview
Go deeper on Rematin IBD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rematin IBD.